Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lundgren

Showing results (531-540 of 681) with videos related to

Pageof 69
Sort By:
The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.
The Journal of Infectious Diseases|October 24, 2007
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patientsFrancesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
AIDS (London, England)|October 27, 2016
The per-protocol effect of immediate versus deferred antiretroviral therapy initiationSara Lodi, Shweta Sharma, Jens D Lundgren, et al.
AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.
Open Forum Infectious Diseases|March 1, 2016
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.
Antiviral Therapy|October 13, 2005
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trialUlrik B Dragsted, Jan Gerstoft, Mike Youle, et al.
HIV Medicine|March 2, 2018
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0L Ryom, C Boesecke, M Bracchi, et al.
American Journal of Respiratory and Critical Care Medicine|July 12, 2008
Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruptionFred M Gordin, Mollie P Roediger, Pierre-Marie Girard, et al.
Pageof 69

Showing results (531-540 of 681) with videos related to

Sort By:
Pageof 69
The Journal of Infectious Diseases|February 5, 2014
Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected personsLeah Shepherd, Jean-Claude Souberbielle, Jean-Philippe Bastard, et al.
The Journal of Infectious Diseases|October 24, 2007
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patientsFrancesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
AIDS (London, England)|October 27, 2016
The per-protocol effect of immediate versus deferred antiretroviral therapy initiationSara Lodi, Shweta Sharma, Jens D Lundgren, et al.
AIDS (London, England)|October 4, 2008
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAntonella d'Arminio Monforte, Donald Abrams, Christian Pradier, et al.
Open Forum Infectious Diseases|March 1, 2016
Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs StudyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.
Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.
Antiviral Therapy|October 13, 2005
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trialUlrik B Dragsted, Jan Gerstoft, Mike Youle, et al.
HIV Medicine|March 2, 2018
Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0L Ryom, C Boesecke, M Bracchi, et al.
American Journal of Respiratory and Critical Care Medicine|July 12, 2008
Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruptionFred M Gordin, Mollie P Roediger, Pierre-Marie Girard, et al.
Pageof 69